Altogether, our findings strongly suggest that stimulation of the hERG1 potassium channels in breast cancer cells induces a calcium-dependent degradation of cyclin E2 via activation of an ubiquitin-dependent proteasome pathway (Figure 7). The gene discussed is CCNE2; the disease is breast cancer.